Italy Gives $21 Million to BU’s CARB-X
Italy awarded CARB-X (Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator) $21 million to help advance new antibiotics, vaccines, and rapid diagnostics for infections that don’t respond to existing treatments. CARB-X is based at the Boston University School of Law.
